Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Benzimidazole derivatives as ERBB tyrosine kinase inhibitors for the treatment of cancer

Benzimidazole derivatives as ERBB tyrosine kinase inhibitors for the treatment of cancer

US Patent 11242352 · Granted Feb 8, 2022

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Substituted quinazoline compounds and methods of use thereof2025
Substituted piperazines as inhibitors of KRAS G12C2025
Substituted quinazolines as inhibitors of KRAS G12C2024
Benzimidazole derivatives, and pharmaceutical compositions and methods of use th2023
Benzimidazole derivatives as ERBB tyrosine kinase inhibitors for the treatment o2023
Benzimidazoles for use in the treatment of cancer and inflammatory diseases2022
2-substituted quinazoline compounds comprising a substituted heterocyclic group 2021
Inhibitors of KRAS G12C mutant proteins2021
Substituted cinnolines as inhibitors of KRAS G12C2021
Inhibitors of KRAS G12C mutant proteins2021
Inhibitors of KRAS G12C mutant proteins2020
Inhibitors of KRAS G12C mutant proteins2020